[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Verapamil.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be decreased when combined with Verapamil.]
[B01AD01, streptokinase, The risk or severity of adverse effects can be increased when Streptokinase is combined with Verapamil.]
[J01GA01, streptomycin, Verapamil may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[L04AA27, fingolimod, The risk or severity of bradycardia can be increased when Verapamil is combined with Fingolimod.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01CG01, sulbactam, Verapamil may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The metabolism of Sulfadiazine can be decreased when combined with Verapamil.]
[S01AB01, sulfamethizole, The metabolism of Verapamil can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Verapamil can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Verapamil can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Verapamil can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Sulfinpyrazone can be decreased when combined with Verapamil.]
[S01AB02, sulfisoxazole, The metabolism of Verapamil can be decreased when combined with Sulfisoxazole.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A10BB04, glibornuride, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Glibornuride.]
[A10BC01, glymidine, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Glymidine.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06DA01, tacrine, The metabolism of Verapamil can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Verapamil.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Verapamil.]
[R03CC03, terbutaline, The therapeutic efficacy of Terbutaline can be decreased when used in combination with Verapamil.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Verapamil.]
[G03BA03, testosterone, The metabolism of Testosterone can be decreased when combined with Verapamil.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Verapamil.]
[S03AA02, tetracycline, The metabolism of Tetracycline can be decreased when combined with Verapamil.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N05AE05, lurasidone, The metabolism of Lurasidone can be decreased when combined with Verapamil.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Verapamil.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Verapamil.]
[L04AX02, thalidomide, The metabolism of Verapamil can be increased when combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The serum concentration of Theophylline can be increased when it is combined with Verapamil.]
[P02CA02, thiabendazole, The metabolism of Verapamil can be decreased when combined with Thiabendazole.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Verapamil is combined with Thiamine.]
[R06AD03, thiethylperazine, Thiethylperazine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Verapamil.]
[N05CA19, thiopental, Thiopental may increase the hypotensive activities of Verapamil.]
[N05AB08, thioproperazine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Thioproperazine.]
[N05AC02, thioridazine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Thioridazine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Verapamil.]
[C01BB04, aprindine, Verapamil may increase the arrhythmogenic activities of Aprindine.]
[G04BE06, moxisylyte, Verapamil may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Verapamil may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Verapamil can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Timolol.]
[P01AB02, tinidazole, The metabolism of Tinidazole can be decreased when combined with Verapamil.]
[S01AA12, tobramycin, Verapamil may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Tolazamide.]
[M02AX02, tolazoline, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tolazoline.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Verapamil.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Verapamil.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the orthostatic hypotensive activities of Verapamil.]
[N06AX05, trazodone, Trazodone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Verapamil.]
[S01BA05, triamcinolone, The metabolism of Triamcinolone can be decreased when combined with Verapamil.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The metabolism of Triazolam can be decreased when combined with Verapamil.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Verapamil may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trifluoperazine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[R03BA07, mometasone, The metabolism of Verapamil can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Verapamil may increase the arrhythmogenic activities of Trimebutine.]
[S01ED04, metipranolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Metipranolol.]
[N03AC02, trimethadione, Trimethadione may increase the arrhythmogenic activities of Verapamil.]
[C02BA01, trimethaphan, Verapamil may increase the hypotensive activities of Trimethaphan.]
[J01EA01, trimethoprim, The metabolism of Trimethoprim can be decreased when combined with Verapamil.]
[N06AA06, trimipramine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Trimipramine.]
[J01FA08, troleandomycin, The metabolism of Verapamil can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Verapamil.]
[C09CA09, azilsartan medoxomil, The risk or severity of adverse effects can be increased when Verapamil is combined with Azilsartan medoxomil.]
[M03AA02, tubocurarine, Verapamil may increase the neuromuscular blocking activities of Tubocurarine.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Verapamil.]
[L01FX04, ipilimumab, Verapamil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Verapamil.]
[R02AA14, oxyquinoline, Verapamil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The serum concentration of Verapamil can be increased when it is combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Linagliptin can be decreased when combined with Verapamil.]
[J05AP03, boceprevir, The serum concentration of Verapamil can be increased when it is combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Verapamil can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be increased when it is combined with Verapamil.]
[S01AA28, vancomycin, Verapamil may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Verapamil may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, The metabolism of Rivaroxaban can be decreased when combined with Verapamil.]
[R03AC18, indacaterol, The therapeutic efficacy of Indacaterol can be decreased when used in combination with Verapamil.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Verapamil can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Verapamil.]
[C04AX07, vincamine, Verapamil may increase the hypotensive activities of Vincamine.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Verapamil.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Verapamil.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A11HA03, vitamin E, The metabolism of Vitamin E can be decreased when combined with Verapamil.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Verapamil.]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be decreased when combined with Verapamil.]
[N01AX15, xenon, The risk or severity of myocardial depression can be increased when Verapamil is combined with Xenon.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MB04, pipemidic acid, The metabolism of Verapamil can be decreased when combined with Pipemidic acid.]
[J05AF01, zidovudine, The metabolism of Zidovudine can be decreased when combined with Verapamil.]
[N05AF05, zuclopenthixol, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Verapamil can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Verapamil can be increased when it is combined with Vemurafenib.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Verapamil.]
[M05BA05, tiludronic acid, Verapamil may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Verapamil may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, Crizotinib may increase the bradycardic activities of Verapamil.]
[R03DC01, zafirlukast, The metabolism of Verapamil can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Verapamil can be decreased when combined with Rabeprazole.]
[J01MA13, trovafloxacin, The metabolism of Verapamil can be decreased when combined with Trovafloxacin.]
[N05AE04, ziprasidone, Ziprasidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be decreased when combined with Verapamil.]
[V03AC02, deferiprone, Verapamil may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The risk or severity of bleeding can be increased when Verapamil is combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, Ruxolitinib may increase the bradycardic activities of Verapamil.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Verapamil.]
[J01DH04, doripenem, Verapamil may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Atenolol.]
[L03AB11, peginterferon alfa-2a, The metabolism of Verapamil can be decreased when combined with Peginterferon alfa-2a.]
[J02AC03, voriconazole, The metabolism of Verapamil can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, Verapamil may increase the neuromuscular blocking activities of Atracurium.]
[S01FA01, atropine, Atropine may increase the arrhythmogenic activities of Verapamil.]
[M01CB03, auranofin, Verapamil may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Verapamil.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Verapamil.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Verapamil.]
[H02AB11, prednylidene, The metabolism of Prednylidene can be decreased when combined with Verapamil.]
[B03XA04, peginesatide, Verapamil may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Verapamil may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Verapamil.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Verapamil.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[G04BE10, avanafil, The metabolism of Avanafil can be decreased when combined with Verapamil.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Verapamil.]
[G04BD12, mirabegron, The therapeutic efficacy of Mirabegron can be decreased when used in combination with Verapamil.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be increased when it is combined with Verapamil.]
[V03AX03, cobicistat, The metabolism of Verapamil can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Verapamil can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Verapamil can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Verapamil.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Verapamil.]
[L04AA31, teriflunomide, The serum concentration of Verapamil can be decreased when it is combined with Teriflunomide.]
[A02AA05, magnesium silicate, The risk or severity of hypotension can be increased when Magnesium silicate is combined with Verapamil.]
[C01CA18, octopamine, The therapeutic efficacy of Octopamine can be decreased when used in combination with Verapamil.]
[H02AA01, aldosterone, The metabolism of Aldosterone can be decreased when combined with Verapamil.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be increased when it is combined with Verapamil.]
[N05CA04, barbital, Barbital may increase the hypotensive activities of Verapamil.]
[C01AA01, acetyldigitoxin, Acetyldigitoxin may increase the arrhythmogenic activities of Verapamil.]
[D02BA02, octinoxate, Verapamil may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Verapamil can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Verapamil.]
[N04BD02, rasagiline, Rasagiline may increase the orthostatic hypotensive activities of Verapamil.]
[C08CA13, lercanidipine, Lercanidipine may increase the arrhythmogenic activities of Verapamil.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Verapamil.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Verapamil.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Verapamil.]
[N02CC03, zolmitriptan, The metabolism of Verapamil can be decreased when combined with Zolmitriptan.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Verapamil.]
[V09IX04, fluorodeoxyglucose F18, Verapamil may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[N01AA01, ethyl ether, The risk or severity of myocardial depression can be increased when Verapamil is combined with Diethyl ether.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Verapamil.]
[H01CB05, pasireotide, Verapamil may increase the bradycardic activities of Pasireotide.]
[G04BE03, sildenafil, The risk or severity of hypotension and syncope can be increased when Sildenafil is combined with Verapamil.]
[V08CA11, gadofosveset, Verapamil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Verapamil.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Verapamil.]
[A16AX08, teduglutide, Verapamil may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Verapamil.]
[J04AK05, bedaquiline, The metabolism of Bedaquiline can be decreased when combined with Verapamil.]
[C04AX11, bencyclane, Verapamil may increase the arrhythmogenic activities of Bencyclane.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Verapamil.]
[A16AX09, glycerol phenylbutyrate, Verapamil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Verapamil.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Verapamil.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A10BK02, canagliflozin, The metabolism of Canagliflozin can be decreased when combined with Verapamil.]
[J01MA15, gemifloxacin, The metabolism of Verapamil can be decreased when combined with Gemifloxacin.]
[M04AB03, benzbromarone, The metabolism of Verapamil can be decreased when combined with Benzbromarone.]
[A12CC09, magnesium orotate, The risk or severity of hypotension can be increased when Magnesium orotate is combined with Verapamil.]
[S01AE07, moxifloxacin, The metabolism of Verapamil can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The serum concentration of Tegaserod can be increased when it is combined with Verapamil.]
[A10AE05, insulin detemir, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin detemir.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Verapamil.]
[A10BX05, pramlintide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Pramlintide.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Verapamil.]
[L03AA12, ancestim, Verapamil may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Verapamil.]
[L04AA18, everolimus, The serum concentration of Everolimus can be increased when it is combined with Verapamil.]
[A12CC05, magnesium aspartate, The risk or severity of hypotension can be increased when Magnesium aspartate is combined with Verapamil.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Verapamil.]
[L01EC02, dabrafenib, The serum concentration of Verapamil can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01EE01, trametinib, The metabolism of Verapamil can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Verapamil.]
[V09AX05, florbetapir F-18, Verapamil may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Verapamil.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Verapamil.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be increased when it is combined with Verapamil.]
[C08EA02, bepridil, Verapamil may increase the arrhythmogenic activities of Bepridil.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Verapamil.]
[A10BJ03, lixisenatide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Lixisenatide.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Verapamil.]
[C02KX04, macitentan, The metabolism of Macitentan can be decreased when combined with Verapamil.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Verapamil.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Verapamil.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be decreased when combined with Verapamil.]
[N03AF04, eslicarbazepine, The metabolism of Verapamil can be decreased when combined with Eslicarbazepine.]
[D01AC18, luliconazole, The serum concentration of Verapamil can be increased when it is combined with Luliconazole.]
[J05AP05, simeprevir, The metabolism of Simeprevir can be decreased when combined with Verapamil.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be increased when it is combined with Verapamil.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Verapamil.]
[C01CA27, droxidopa, The therapeutic efficacy of Droxidopa can be decreased when used in combination with Verapamil.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Acebutolol.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Verapamil.]
[A16AA07, metreleptin, The metabolism of Verapamil can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Verapamil can be increased when combined with Apremilast.]
[L02BG02, formestane, Verapamil may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The metabolism of Betamethasone can be decreased when combined with Verapamil.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Betaxolol.]
[V03AB34, fomepizole, Verapamil may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C02CC01, bethanidine, The therapeutic efficacy of Bethanidine can be decreased when used in combination with Verapamil.]
[C10AB02, bezafibrate, The metabolism of Bezafibrate can be decreased when combined with Verapamil.]
[A10BJ04, albiglutide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Albiglutide.]
[L04AC11, siltuximab, The metabolism of Verapamil can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, Verapamil may increase the bradycardic activities of Ceritinib.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Verapamil.]
[A03BA03, hyoscyamine, Hyoscyamine may increase the arrhythmogenic activities of Verapamil.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Verapamil.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Verapamil.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Verapamil.]
[A10BK03, empagliflozin, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Empagliflozin.]
[R03AC19, olodaterol, The therapeutic efficacy of Olodaterol can be decreased when used in combination with Verapamil.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Verapamil.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Verapamil.]
[J01XA05, oritavancin, The metabolism of Verapamil can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N05AA04, acepromazine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Verapamil.]
[A10BJ05, dulaglutide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Dulaglutide.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Verapamil.]
[A11HA08, tocophersolan, The metabolism of Tocofersolan can be decreased when combined with Verapamil.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Verapamil.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Verapamil.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Verapamil.]
[S03AA06, gentamicin, Verapamil may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Verapamil.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Verapamil.]
[B01AA01, dicumarol, The metabolism of Dicoumarol can be decreased when combined with Verapamil.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Verapamil.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Verapamil.]
[L04AC10, secukinumab, The metabolism of Verapamil can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Verapamil.]
[L01EX08, lenvatinib, The serum concentration of Lenvatinib can be increased when it is combined with Verapamil.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Verapamil.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Verapamil.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Verapamil.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C01EB17, ivabradine, The metabolism of Ivabradine can be decreased when combined with Verapamil.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Verapamil.]
[A07DA06, eluxadoline, The serum concentration of Eluxadoline can be increased when it is combined with Verapamil.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Verapamil.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Verapamil.]
[A04AD14, rolapitant, The metabolism of Rolapitant can be decreased when combined with Verapamil.]
[G02CX02, flibanserin, The metabolism of Flibanserin can be decreased when combined with Verapamil.]
[A06AD03, magnesium peroxide, The risk or severity of hypotension can be increased when Magnesium peroxide is combined with Verapamil.]
[N05AX15, cariprazine, The metabolism of Cariprazine can be decreased when combined with Verapamil.]
[A10BF01, acarbose, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Acarbose.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[A10AE06, insulin degludec, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin degludec.]
[A02BC03, lansoprazole, The metabolism of Verapamil can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Verapamil may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Verapamil.]
[J02AC05, isavuconazole, The metabolism of Isavuconazole can be decreased when combined with Verapamil.]
[L01EB04, osimertinib, The serum concentration of Verapamil can be decreased when it is combined with Osimertinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Verapamil.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Verapamil.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Verapamil.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Verapamil.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Verapamil.]
[A10BB31, acetohexamide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Acetohexamide.]
[G04CA01, alfuzosin, Verapamil may increase the hypotensive activities of Alfuzosin.]
[M04AB05, lesinurad, Verapamil may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Verapamil.]
[J05AP11, grazoprevir, The metabolism of Grazoprevir can be decreased when combined with Verapamil.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N02BA02, aloxiprin, The risk or severity of bleeding can be increased when Verapamil is combined with Aloxiprin.]
[N03AX23, brivaracetam, The metabolism of Brivaracetam can be decreased when combined with Verapamil.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be increased when it is combined with Verapamil.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Verapamil.]
[N04BC01, bromocriptine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Verapamil may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[R06AB01, brompheniramine, The metabolism of Brompheniramine can be decreased when combined with Verapamil.]
[C08CA01, amlodipine, Amlodipine may increase the arrhythmogenic activities of Verapamil.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be increased when combined with Verapamil.]
[A05AA04, obeticholic acid, The metabolism of Verapamil can be decreased when combined with Obeticholic acid.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01ED03, levobunolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Levobunolol.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Verapamil.]
[C07AA19, bupranolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Bupranolol.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Verapamil.]
[N05BE01, buspirone, The serum concentration of Buspirone can be increased when it is combined with Verapamil.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Verapamil.]
[L01XX27, arsenic trioxide, The risk or severity of adverse effects can be increased when Verapamil is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, Verapamil may increase the bradycardic activities of Rivastigmine.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Verapamil.]
[M02AA03, clofezone, The metabolism of Verapamil can be decreased when combined with Rabeprazole.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Verapamil.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Verapamil.]
[S01AA26, azithromycin, The metabolism of Azithromycin can be decreased when combined with Verapamil.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Verapamil.]
[L01EF02, ribociclib, The metabolism of Verapamil can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of bleeding can be increased when Verapamil is combined with Balsalazide.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Verapamil.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Verapamil.]
[A06AH05, naldemedine, Verapamil may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Verapamil.]
[N02BF02, pregabalin, Pregabalin may increase the bradycardic activities of Verapamil.]
[N06BC01, caffeine, The metabolism of Verapamil can be decreased when combined with Caffeine.]
[C09AA07, benazepril, The risk or severity of adverse effects can be increased when Benazepril is combined with Verapamil.]
[A10BX06, benfluorex, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Benfluorex.]
[D05AX03, calcitriol, The metabolism of Calcitriol can be decreased when combined with Verapamil.]
[P01CA02, benznidazole, Verapamil may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[G04BA03, calcium chloride, The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium chloride.]
[J01XX08, linezolid, Linezolid may increase the orthostatic hypotensive activities of Verapamil.]
[J05AF06, abacavir, Verapamil may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Verapamil can be decreased when combined with Tipranavir.]
[D11AX03, calcium gluconate, The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium gluconate.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Verapamil.]
[L04AB02, infliximab, The metabolism of Verapamil can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Verapamil can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Verapamil.]
[N04BD03, safinamide, Safinamide may increase the orthostatic hypotensive activities of Verapamil.]
[J01MA23, delafloxacin, Verapamil may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Verapamil.]
[D01AC10, bifonazole, The therapeutic efficacy of Bifonazole can be increased when used in combination with Verapamil.]
[P03AC02, bioallethrin, Verapamil may increase the arrhythmogenic activities of Bioallethrin.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Verapamil is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Verapamil.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Verapamil.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Verapamil.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Verapamil.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Verapamil.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Verapamil.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Bisoprolol.]
[R03AC17, bitolterol, The therapeutic efficacy of Bitolterol can be decreased when used in combination with Verapamil.]
[J05AG03, efavirenz, The serum concentration of Verapamil can be decreased when it is combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C07AA17, bopindolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Bopindolol.]
[C01DX19, nesiritide, The risk or severity of adverse effects can be increased when Verapamil is combined with Nesiritide.]
[N05CD09, brotizolam, The metabolism of Brotizolam can be decreased when combined with Verapamil.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Budesonide can be decreased when combined with Verapamil.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Verapamil.]
[J05AX18, letermovir, The metabolism of Verapamil can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Verapamil.]
[A10BJ06, semaglutide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Semaglutide.]
[N01BX04, capsaicin, The metabolism of Verapamil can be increased when combined with Capsaicin.]
[A10BK04, ertugliflozin, The serum concentration of Ertugliflozin can be increased when it is combined with Verapamil.]
[R06AX18, acrivastine, Verapamil may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The risk or severity of adverse effects can be increased when Verapamil is combined with Captopril.]
[V04CD06, macimorelin, The metabolism of Macimorelin can be decreased when combined with Verapamil.]
[L02BB05, apalutamide, The serum concentration of Verapamil can be increased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The serum concentration of Carbamazepine can be increased when it is combined with Verapamil.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Verapamil.]
[L03AB06, interferon alfa-n1, The metabolism of Verapamil can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The risk or severity of adverse effects can be increased when Verapamil is combined with Carvedilol.]
[B02BX09, fostamatinib, The risk or severity of hypotension and syncope can be increased when Fostamatinib is combined with Verapamil.]
[N03AX24, cannabidiol, The metabolism of Cannabidiol can be decreased when combined with Verapamil.]
[B02BX08, avatrombopag, The serum concentration of Avatrombopag can be increased when it is combined with Verapamil.]
[L04AA37, baricitinib, The metabolism of Baricitinib can be decreased when combined with Verapamil.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Verapamil.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Verapamil.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01GB14, plazomicin, Verapamil may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Celiprolol.]
[H01CC03, elagolix, The serum concentration of Elagolix can be increased when it is combined with Verapamil.]
[L01XX62, ivosidenib, The metabolism of Ivosidenib can be decreased when combined with Verapamil.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Verapamil.]
[A16AX14, migalastat, Verapamil may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Verapamil can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Verapamil.]
[J05AX24, tecovirimat, The metabolism of Verapamil can be decreased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Verapamil.]
[J01AA13, eravacycline, The metabolism of Eravacycline can be decreased when combined with Verapamil.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Verapamil.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be increased when it is combined with Verapamil.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Verapamil.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A10BB06, carbutamide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Carbutamide.]
[D08AE05, chloroxylenol, Verapamil may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Verapamil.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Verapamil.]
[M03BA02, carisoprodol, The metabolism of Verapamil can be decreased when combined with Carisoprodol.]
[R03BB08, revefenacin, Verapamil may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Verapamil.]
[L04AA39, emapalumab, The metabolism of Verapamil can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Verapamil can be decreased when combined with Carmustine.]
[L01EX12, larotrectinib, The metabolism of Larotrectinib can be decreased when combined with Verapamil.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Verapamil.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Verapamil.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Verapamil.]
[C01BG07, cifenline, Verapamil may increase the arrhythmogenic activities of Cibenzoline.]
[C09AA08, cilazapril, The risk or severity of adverse effects can be increased when Verapamil is combined with Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Verapamil.]
[S01ED05, carteolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Carteolol.]
[P02BX04, triclabendazole, The metabolism of Verapamil can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Esketamine can be decreased when combined with Verapamil.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Verapamil is combined with Siponimod.]
[J01FA09, clarithromycin, The risk or severity of adverse effects can be increased when Clarithromycin is combined with Verapamil.]
[N06BA14, solriamfetol, Verapamil may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Verapamil.]
[N05BA09, clobazam, The metabolism of Clobazam can be decreased when combined with Verapamil.]
[H02AB14, cloprednol, The metabolism of Verapamil can be increased when combined with Cloprednol.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Verapamil.]
[V03AE07, calcium acetate, The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium acetate.]
[C09CA06, candesartan, The metabolism of Verapamil can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Verapamil can be increased when combined with Etanercept.]
[A12CC06, magnesium lactate, The risk or severity of hypotension can be increased when Magnesium lactate is combined with Verapamil.]
[H02AB17, cortivazol, The metabolism of Verapamil can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The serum concentration of Verapamil can be decreased when it is combined with Alpelisib.]
[L01FX14, polatuzumab vedotin, The metabolism of Polatuzumab vedotin can be decreased when combined with Verapamil.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01XX66, selinexor, The metabolism of Selinexor can be decreased when combined with Verapamil.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L02BB06, darolutamide, The metabolism of Darolutamide can be decreased when combined with Verapamil.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Verapamil.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C03BX03, cicletanine, Verapamil may increase the arrhythmogenic activities of Cicletanine.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Verapamil.]
[L04AA44, upadacitinib, The metabolism of Upadacitinib can be decreased when combined with Verapamil.]
[L01EJ02, fedratinib, The metabolism of Fedratinib can be decreased when combined with Verapamil.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Verapamil.]
[N07XX11, pitolisant, The serum concentration of Verapamil can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The serum concentration of Pretomanid can be increased when it is combined with Verapamil.]
[J01XX12, lefamulin, Verapamil may decrease the excretion rate of Lefamulin which could result in a higher serum level.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Verapamil.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Verapamil.]
[A10AE03, insulin, regular, pork, The metabolism of Verapamil can be increased when combined with Insulin pork.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Verapamil.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Verapamil.]
[J01DB01, cephalexin, The metabolism of Cephalexin can be decreased when combined with Verapamil.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[H02AB13, deflazacort, The serum concentration of Deflazacort can be increased when it is combined with Verapamil.]
[G03DB05, demegestone, The metabolism of Demegestone can be decreased when combined with Verapamil.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Verapamil.]
[N02CC08, lasmiditan, Lasmiditan may increase the bradycardic activities of Verapamil.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Verapamil.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Verapamil.]
[B06AX03, voxelotor, The serum concentration of Voxelotor can be increased when it is combined with Verapamil.]
[N03AX25, cenobamate, The serum concentration of Verapamil can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Verapamil can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Verapamil may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Verapamil.]
[L01FX13, enfortumab vedotin, The metabolism of Enfortumab vedotin can be decreased when combined with Verapamil.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Verapamil.]
[S01XA12, dexpanthenol, Verapamil may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Verapamil.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Verapamil.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Verapamil.]
[N05AD10, lumateperone, The serum concentration of Lumateperone can be increased when it is combined with Verapamil.]
[M01AX21, diacetylrhein, The metabolism of Verapamil can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Verapamil.]
[J05AB16, remdesivir, The metabolism of Remdesivir can be decreased when combined with Verapamil.]
[S01AE06, gatifloxacin, The metabolism of Verapamil can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Osilodrostat can be decreased when combined with Verapamil.]
[J05AE05, amprenavir, The metabolism of Verapamil can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Verapamil.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Verapamil.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Verapamil.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Verapamil.]
[R02AA03, dichlorobenzyl alcohol, Verapamil may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, The metabolism of Dienogest can be decreased when combined with Verapamil.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Verapamil.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Verapamil.]
[M01AH02, rofecoxib, The metabolism of Verapamil can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Bexarotene can be decreased when combined with Verapamil.]
[C08CA16, clevidipine, Verapamil may increase the arrhythmogenic activities of Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Verapamil can be increased when it is combined with Dronedarone.]
[S03AA08, chloramphenicol, The metabolism of Verapamil can be decreased when combined with Chloramphenicol.]
[C02AA06, methoserpidine, Verapamil may increase the hypotensive activities of Methoserpidine.]
[L01EN02, pemigatinib, The metabolism of Pemigatinib can be decreased when combined with Verapamil.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Verapamil.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be increased when it is combined with Verapamil.]
[N04BX04, opicapone, The risk or severity of adverse effects can be increased when Verapamil is combined with Opicapone.]
[C01CA14, dopexamine, The therapeutic efficacy of Dopexamine can be decreased when used in combination with Verapamil.]
[D07XB03, fluprednidene, The metabolism of Fluprednidene can be decreased when combined with Verapamil.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Verapamil.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01EX19, ripretinib, The metabolism of Ripretinib can be decreased when combined with Verapamil.]
[V08CA05, mangafodipir, Verapamil may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be increased when it is combined with Verapamil.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N05CM02, chlormethiazole, The metabolism of Clomethiazole can be decreased when combined with Verapamil.]
[L01XX69, lurbinectedin, The serum concentration of Lurbinectedin can be increased when it is combined with Verapamil.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Verapamil.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Verapamil.]
[J05AX29, fostemsavir, The metabolism of Fostemsavir can be decreased when combined with Verapamil.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Verapamil.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Verapamil.]
[L04AC19, satralizumab, The serum concentration of Verapamil can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Verapamil.]
[P01BA01, chloroquine, The metabolism of Chloroquine can be decreased when combined with Verapamil.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Verapamil.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Verapamil.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[A10BB02, chlorpropamide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Chlorpropamide.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Verapamil.]
[A11CC05, cholecalciferol, The metabolism of Cholecalciferol can be decreased when combined with Verapamil.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Verapamil.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N02BA03, choline salicylate, The risk or severity of bleeding can be increased when Verapamil is combined with Choline salicylate.]
[N06BX18, vinpocetine, Verapamil may increase the arrhythmogenic activities of Vinpocetine.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be decreased when combined with Verapamil.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Verapamil.]
[A16AX20, lonafarnib, The metabolism of Verapamil can be decreased when combined with Lonafarnib.]
[M09AA01, hydroquinine, Verapamil may increase the arrhythmogenic activities of Hydroquinine.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Verapamil.]
[M01AX25, chondroitin sulfates, Verapamil may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[L04AD03, voclosporin, The metabolism of Voclosporin can be decreased when combined with Verapamil.]
[P03AX07, abametapir, The serum concentration of Verapamil can be increased when it is combined with Abametapir.]
[C01DX22, vericiguat, The risk or severity of adverse effects can be increased when Verapamil is combined with Vericiguat.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Verapamil.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Verapamil.]
[N03AX10, felbamate, The metabolism of Felbamate can be decreased when combined with Verapamil.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Verapamil.]
[C01CA19, fenoldopam, The risk or severity of adverse effects can be increased when Verapamil is combined with Fenoldopam.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Verapamil.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01MB07, flumequine, The metabolism of Verapamil can be decreased when combined with Flumequine.]
[S02BA08, fluocinolone acetonide, The metabolism of Fluocinolone acetonide can be decreased when combined with Verapamil.]
[N02BG07, flupirtine, Verapamil may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The therapeutic efficacy of Formoterol can be decreased when used in combination with Verapamil.]
[A10AF01, insulin, regular, human, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin human.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Verapamil.]
[L01EK03, tivozanib, The serum concentration of Tivozanib can be increased when it is combined with Verapamil.]
[N01AB05, trichloroethylene, The risk or severity of myocardial depression can be increased when Verapamil is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Verapamil can be increased when it is combined with Peginterferon alfa-2b.]
[H04AA02, dasiglucagon, Verapamil may increase the hypotensive activities of Dasiglucagon.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Verapamil.]
[A02BA01, cimetidine, The serum concentration of Verapamil can be increased when it is combined with Cimetidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N07CA02, cinnarizine, Cinnarizine may increase the arrhythmogenic activities of Verapamil.]
[J01MB06, cinoxacin, The metabolism of Verapamil can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Verapamil can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Verapamil.]
[S03AA07, ciprofloxacin, The metabolism of Verapamil can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Verapamil may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The metabolism of Citalopram can be decreased when combined with Verapamil.]
[H01AC07, somapacitan, The metabolism of Verapamil can be decreased when combined with Somapacitan.]
[J02AX07, ibrexafungerp, The metabolism of Ibrexafungerp can be decreased when combined with Verapamil.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Verapamil.]
[L04AA48, belumosudil, The metabolism of Belumosudil can be decreased when combined with Verapamil.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Verapamil is combined with Fexinidazole.]
[L01XX74, belzutifan, The metabolism of Belzutifan can be decreased when combined with Verapamil.]
[H01AC09, lonapegsomatropin, The metabolism of Verapamil can be increased when combined with Lonapegsomatropin.]
[L01EB10, mobocertinib, The metabolism of Mobocertinib can be decreased when combined with Verapamil.]
[L01FX23, tisotumab vedotin, The metabolism of Tisotumab vedotin can be decreased when combined with Verapamil.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Verapamil.]
[V09AB03, ioflupane I-123, Verapamil may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Verapamil.]
[V09AA01, technetium Tc 99m exametazime, Verapamil may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Verapamil may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[L04AA59, avacopan, The metabolism of Avacopan can be decreased when combined with Verapamil.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Verapamil.]
[A10BB12, glimepiride, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Glimepiride.]
[A10BB08, gliquidone, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Gliquidone.]
[R03CC13, clenbuterol, The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Verapamil.]
[A12AA02, calcium glubionate, The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium glubionate anhydrous.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Verapamil.]
[N06AX25, St. John's wort extract, The metabolism of Verapamil can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Asciminib can be decreased when combined with Verapamil.]
[L02BG06, exemestane, The metabolism of Exemestane can be decreased when combined with Verapamil.]
[J05AX10, maribavir, The metabolism of Maribavir can be decreased when combined with Verapamil.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Verapamil can be decreased when combined with Ropeginterferon alfa-2b.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Verapamil.]
[J04BA01, clofazimine, The metabolism of Verapamil can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Clofibrate can be decreased when combined with Verapamil.]
[B06AX04, mitapivat, The metabolism of Mitapivat can be decreased when combined with Verapamil.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Verapamil.]
[L01EJ03, pacritinib, The serum concentration of Pacritinib can be increased when it is combined with Verapamil.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Verapamil.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Verapamil.]
[N03AE01, clonazepam, The metabolism of Clonazepam can be decreased when combined with Verapamil.]
[S01EA04, clonidine, Verapamil may increase the atrioventricular blocking (AV block) activities of Clonidine.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Verapamil.]
[C01EB24, mavacamten, The serum concentration of Mavacamten can be increased when it is combined with Verapamil.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A10BX16, tirzepatide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Tirzepatide.]
[J02AC06, oteseconazole, The therapeutic efficacy of Oteseconazole can be increased when used in combination with Verapamil.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Verapamil.]
[H01CC04, linzagolix, The serum concentration of Verapamil can be increased when it is combined with Linzagolix.]
[N05BA21, clotiazepam, The metabolism of Clotiazepam can be decreased when combined with Verapamil.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Verapamil.]
[A04AA02, granisetron, The metabolism of Granisetron can be decreased when combined with Verapamil.]
[N05AH02, clozapine, Clozapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Verapamil.]
[A10BX01, guar gum, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Guar gum.]
[A10BK06, sotagliflozin, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Sotagliflozin.]
[J01GB12, arbekacin, Verapamil may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Verapamil can be increased when combined with Somatrogon.]
[M09AX11, palovarotene, The metabolism of Palovarotene can be decreased when combined with Verapamil.]
[C02KB01, metyrosine, Verapamil may increase the hypotensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Verapamil can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Verapamil.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Verapamil.]
[J01XB01, colistin, Verapamil may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L04AA13, leflunomide, The serum concentration of Verapamil can be decreased when it is combined with Leflunomide.]
[C01BA13, hydroquinidine, Verapamil may increase the arrhythmogenic activities of Hydroquinidine.]
[A02AD04, hydrotalcite, The risk or severity of hypotension can be increased when Hydrotalcite is combined with Verapamil.]
[N01AB07, desflurane, The risk or severity of myocardial depression can be increased when Verapamil is combined with Desflurane.]
[A04AA03, tropisetron, Verapamil may increase the arrhythmogenic activities of Tropisetron.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Verapamil.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[H01AC03, mecasermin, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Mecasermin.]
[A10AE04, insulin glargine, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin glargine.]
[J01FA15, telithromycin, The risk or severity of adverse effects can be increased when Telithromycin is combined with Verapamil.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Verapamil.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J05AB14, valganciclovir, Verapamil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[J05AF09, emtricitabine, The excretion of Emtricitabine can be decreased when combined with Verapamil.]
[C05BB03, invert sugar, Verapamil may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Verapamil may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Verapamil may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Verapamil may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Verapamil may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The metabolism of Valdecoxib can be decreased when combined with Verapamil.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Verapamil.]
[A03AX10, isometheptene, The therapeutic efficacy of Isometheptene can be decreased when used in combination with Verapamil.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Verapamil.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Verapamil.]
[J02AC02, itraconazole, The metabolism of Verapamil can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Verapamil.]
[N05BA10, ketazolam, The metabolism of Ketazolam can be decreased when combined with Verapamil.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01EA01, imatinib, The metabolism of Imatinib can be decreased when combined with Verapamil.]
[J02AC04, posaconazole, The metabolism of Verapamil can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The metabolism of Esomeprazole can be decreased when combined with Verapamil.]
[C08CA09, lacidipine, Verapamil may increase the hypotensive activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Verapamil.]
[N03AX09, lamotrigine, Lamotrigine may increase the arrhythmogenic activities of Verapamil.]
[S01BA03, cortisone, The metabolism of Verapamil can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The therapeutic efficacy of Lofexidine can be decreased when used in combination with Verapamil.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be decreased when combined with Verapamil.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[R06AX13, loratadine, The metabolism of Loratadine can be decreased when combined with Verapamil.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C09AA03, lisinopril, The risk or severity of adverse effects can be increased when Verapamil is combined with Lisinopril.]
[A02AD02, magaldrate, The risk or severity of hypotension can be increased when Magaldrate is combined with Verapamil.]
[A06AD01, magnesium carbonate, The risk or severity of hypotension can be increased when Magnesium carbonate is combined with Verapamil.]
[C08CA11, manidipine, Verapamil may increase the arrhythmogenic activities of Manidipine.]
[C07AA14, mepindolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Mepindolol.]
[H02AB15, meprednisone, The metabolism of Meprednisone can be decreased when combined with Verapamil.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Verapamil.]
[J01DH02, meropenem, Verapamil may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C01EB10, adenosine, Adenosine may increase the arrhythmogenic activities of Verapamil.]
[C04AX01, cyclandelate, Verapamil may increase the arrhythmogenic activities of Cyclandelate.]
[R03CB02, methoxyphenamine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Methoxyphenamine.]
[R06AE03, cyclizine, The metabolism of Verapamil can be decreased when combined with Cyclizine.]
[C03DA04, eplerenone, The metabolism of Eplerenone can be decreased when combined with Verapamil.]
[N05AD03, metylperon, Verapamil may increase the arrhythmogenic activities of Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA03, midecamycin, The metabolism of Midecamycin can be decreased when combined with Verapamil.]
[A10BF02, miglitol, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Miglitol.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Verapamil.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Verapamil.]
[N06AX07, minaprine, Minaprine may increase the orthostatic hypotensive activities of Verapamil.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be increased when it is combined with Verapamil.]
[N06AG02, moclobemide, Moclobemide may increase the orthostatic hypotensive activities of Verapamil.]
[N06BA07, modafinil, The metabolism of Verapamil can be decreased when combined with Armodafinil.]
[C09AA13, moexipril, The risk or severity of adverse effects can be increased when Verapamil is combined with Moexipril.]
[C10AA07, rosuvastatin, The metabolism of Rosuvastatin can be decreased when combined with Verapamil.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Verapamil can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The therapeutic efficacy of Moxonidine can be decreased when used in combination with Verapamil.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Verapamil is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Verapamil can be decreased when combined with Entecavir.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Verapamil.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Verapamil.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Verapamil.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Verapamil.]
[G03XA01, danazol, The metabolism of Verapamil can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Verapamil.]
[J04BA02, dapsone, The metabolism of Dapsone can be decreased when combined with Verapamil.]
[L01DB02, daunorubicin, The metabolism of Verapamil can be increased when combined with Daunorubicin.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Verapamil.]
[A04AD11, nabilone, The metabolism of Nabilone can be decreased when combined with Verapamil.]
[M01AX01, nabumetone, The metabolism of Verapamil can be decreased when combined with Nabumetone.]
[N07BB05, nalmefene, Verapamil may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[B05XA15, potassium lactate, The therapeutic efficacy of Potassium lactate can be decreased when used in combination with Verapamil.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Nebivolol.]
[S01GX04, nedocromil, Verapamil may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nefazodone.]
[C01DX16, nicorandil, Nicorandil may increase the hypotensive activities of Verapamil.]
[L02BB02, nilutamide, The metabolism of Verapamil can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The metabolism of Tiagabine can be decreased when combined with Verapamil.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be decreased when combined with Verapamil.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Verapamil.]
[M03AC11, cisatracurium, Verapamil may increase the neuromuscular blocking activities of Cisatracurium.]
[C01CA05, norfenefrine, The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Verapamil.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Verapamil.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Verapamil.]
[A07EC03, olsalazine, The risk or severity of bleeding can be increased when Verapamil is combined with Olsalazine.]
[N06AA01, desipramine, The metabolism of Desipramine can be decreased when combined with Verapamil.]
[C01AA07, deslanoside, Verapamil may increase the arrhythmogenic activities of Deslanoside.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[V04CH02, indigo carmine, Verapamil may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C09XA02, aliskiren, The metabolism of Aliskiren can be decreased when combined with Verapamil.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The serum concentration of the active metabolites of Oxcarbazepine can be decreased when Oxcarbazepine is used in combination with Verapamil.]
[S03BA01, dexamethasone, The metabolism of Verapamil can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Oxybutynin can be decreased when combined with Verapamil.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Verapamil.]
[L04AB04, adalimumab, The metabolism of Verapamil can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Verapamil.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Amphetamine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Verapamil.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Verapamil.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Verapamil.]
[B01AC04, clopidogrel, The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Verapamil.]
[C01DA05, pentaerythritol tetranitrate, Verapamil may increase the vasodilatory activities of Pentaerythritol tetranitrate.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Verapamil.]
[P03AC04, permethrin, Verapamil may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Diazepam can be decreased when combined with Verapamil.]
[V03AH01, diazoxide, The risk or severity of adverse effects can be increased when Verapamil is combined with Diazoxide.]
[R05DA08, pholcodine, Verapamil may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Verapamil.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A03AA07, dicyclomine, Verapamil may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Verapamil may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[C02DG01, pinacidil, The metabolism of Pinacidil can be decreased when combined with Verapamil.]
[A03AX04, pinaverium, Verapamil may increase the arrhythmogenic activities of Pinaverium.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be decreased when combined with Verapamil.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Verapamil is combined with Pipamperone.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Verapamil.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Verapamil.]
[R03CC07, pirbuterol, The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Verapamil.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA03, diethylpropion, The therapeutic efficacy of Verapamil can be decreased when used in combination with Diethylpropion.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be decreased when combined with Verapamil.]
[C08CA03, isradipine, Isradipine may increase the arrhythmogenic activities of Verapamil.]
[D07XC04, diflucortolone, The metabolism of Difluocortolone can be decreased when combined with Verapamil.]
[N02BA11, diflunisal, The risk or severity of bleeding can be increased when Verapamil is combined with Diflunisal.]
[C01AA04, digitoxin, Verapamil may increase the arrhythmogenic activities of Digitoxin.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Verapamil.]
[C02DB01, dihydralazine, The metabolism of Verapamil can be decreased when combined with Dihydralazine.]
[C10AX09, ezetimibe, The excretion of Ezetimibe can be decreased when combined with Verapamil.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Verapamil.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Verapamil can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Treprostinil can be decreased when combined with Verapamil.]
[H03BC01, potassium perchlorate, Verapamil may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Verapamil may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[C08DB01, diltiazem, Diltiazem may increase the arrhythmogenic activities of Verapamil.]
[V03AB09, dimercaprol, Verapamil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[R03CC08, procaterol, The therapeutic efficacy of Procaterol can be decreased when used in combination with Verapamil.]
[M02AX03, dimethyl sulfoxide, The metabolism of Verapamil can be decreased when combined with Dimethyl sulfoxide.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Verapamil.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[G02AD02, dinoprostone, The risk or severity of adverse effects can be increased when Dinoprostone is combined with Verapamil.]
[C05CA03, diosmin, The metabolism of Verapamil can be decreased when combined with Diosmin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Verapamil.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Verapamil.]
[N05CD10, quazepam, The metabolism of Quazepam can be decreased when combined with Verapamil.]
[C09AA06, quinapril, The risk or severity of adverse effects can be increased when Verapamil is combined with Quinapril.]
[B01AC07, dipyridamole, The risk or severity of hypotension and syncope can be increased when Dipyridamole is combined with Verapamil.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Verapamil.]
[C09AA05, ramipril, The risk or severity of adverse effects can be increased when Ramipril is combined with Verapamil.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Verapamil.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Verapamil.]
[R03CC14, reproterol, The therapeutic efficacy of Reproterol can be decreased when used in combination with Verapamil.]
[S01AX06, resorcinol, Verapamil may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The risk or severity of sinus node depression can be increased when Verapamil is combined with Disopyramide.]
[P03AA04, disulfiram, The metabolism of Disulfiram can be decreased when combined with Verapamil.]
[S02AA12, rifamycin SV, The metabolism of Verapamil can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Verapamil can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Verapamil.]
[N07XX02, riluzole, The metabolism of Riluzole can be decreased when combined with Verapamil.]
[N05AX08, risperidone, The serum concentration of Risperidone can be increased when it is combined with Verapamil.]
[R06AE09, levocetirizine, The metabolism of Levocetirizine can be decreased when combined with Verapamil.]
[N01BB09, ropivacaine, The metabolism of Verapamil can be decreased when combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Verapamil can be decreased when combined with Rosoxacin.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Verapamil.]
[A04AD12, aprepitant, The metabolism of Aprepitant can be decreased when combined with Verapamil.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Verapamil.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Verapamil.]
[J05AE07, fosamprenavir, The metabolism of Fosamprenavir can be decreased when combined with Verapamil.]
[G04BE08, tadalafil, The risk or severity of hypotension and syncope can be increased when Tadalafil is combined with Verapamil.]
[S01BC05, ketorolac, The metabolism of Ketorolac can be decreased when combined with Verapamil.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Verapamil.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Verapamil.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[R03AC12, salmeterol, The metabolism of Verapamil can be decreased when combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C01CA07, dobutamine, The therapeutic efficacy of Dobutamine can be decreased when used in combination with Verapamil.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Verapamil.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Verapamil is combined with Dopamine.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Verapamil.]
[N06AA12, doxepin, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxepin.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Verapamil.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Verapamil.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Verapamil.]
[N01AB08, sevoflurane, The risk or severity of myocardial depression can be increased when Verapamil is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[A08AA10, sibutramine, The metabolism of Sibutramine can be decreased when combined with Verapamil.]
[C10AA01, simvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Verapamil is combined with Simvastatin.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Verapamil.]
[A12CA02, sodium sulfate, The therapeutic efficacy of Sodium sulfate can be decreased when used in combination with Verapamil.]
[C09AA11, spirapril, Verapamil may increase the hypotensive activities of Spirapril.]
[G03DB01, dydrogesterone, The metabolism of Dydrogesterone can be decreased when combined with Verapamil.]
[R03DA01, dyphylline, Dyphylline may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N02CC01, sumatriptan, The excretion of Sumatriptan can be decreased when combined with Verapamil.]
[V04CX07, edrophonium, Verapamil may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Talinolol.]
[H01AA01, corticotropin, The metabolism of Corticotropin can be decreased when combined with Verapamil.]
[J01MA05, temafloxacin, The metabolism of Verapamil can be decreased when combined with Temafloxacin.]
[L01AX03, temozolomide, Verapamil may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[G04CA03, terazosin, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Verapamil.]
[G04BD05, terodiline, Verapamil may increase the arrhythmogenic activities of Terodiline.]
[C07AA16, tertatolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Tertatolol.]
[S01GA02, tetrahydrozoline, The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Verapamil.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Verapamil.]
[C09AA02, enalapril, The risk or severity of adverse effects can be increased when Enalapril is combined with Verapamil.]
[M01AG02, tolfenamic acid, The metabolism of Tolfenamic acid can be decreased when combined with Verapamil.]
[N06AG03, toloxatone, Toloxatone may increase the orthostatic hypotensive activities of Verapamil.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Verapamil.]
[N03AX11, topiramate, The metabolism of Verapamil can be decreased when combined with Topiramate.]
[L02BA02, toremifene, The metabolism of Toremifene can be decreased when combined with Verapamil.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Verapamil may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[R03CC11, tulobuterol, The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Verapamil.]
[N01AB04, enflurane, The risk or severity of myocardial depression can be increased when Verapamil is combined with Enflurane.]
[C02CA06, urapidil, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Urapidil.]
[J01MA04, enoxacin, The metabolism of Verapamil can be decreased when combined with Enoxacin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Verapamil.]
[S01FB02, ephedrine, The therapeutic efficacy of Ephedrine can be decreased when used in combination with Verapamil.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Verapamil.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be decreased when combined with Verapamil.]
[C01CX07, xamoterol, The therapeutic efficacy of Xamoterol can be decreased when used in combination with Verapamil.]
[S01GA03, xylometazoline, Verapamil may increase the arrhythmogenic activities of Xylometazoline.]
[C08CA12, mepirodipine, Verapamil may increase the arrhythmogenic activities of Barnidipine.]
[S01EA01, epinephrine, The therapeutic efficacy of Epinephrine can be decreased when used in combination with Verapamil.]
[C09AA15, zofenopril, Verapamil may increase the hypotensive activities of Zofenopril.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Verapamil.]
[M01AB04, zomepirac, The metabolism of Zomepirac can be decreased when combined with Verapamil.]
[N03AX15, zonisamide, Verapamil may increase the arrhythmogenic activities of Zonisamide.]
[A10AB06, insulin glulisine, human, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin glulisine.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Verapamil.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Verapamil.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C02AC02, guanfacine, The therapeutic efficacy of Guanfacine can be decreased when used in combination with Verapamil.]
[B01AC11, iloprost, The risk or severity of adverse effects can be increased when Verapamil is combined with Iloprost.]
[C01BG01, moricizine, Verapamil may increase the arrhythmogenic activities of Moricizine.]
[G02AB03, ergonovine, The therapeutic efficacy of Ergometrine can be decreased when used in combination with Verapamil.]
[C04AE01, ergoloid mesylates, USP, The metabolism of Ergoloid mesylate can be decreased when combined with Verapamil.]
[N02CA02, ergotamine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Ergotamine.]
[C01DA13, erythrityl tetranitrate, Verapamil may increase the vasodilatory activities of Erythrityl tetranitrate.]
[L03AX05, pidotimod, Verapamil may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The risk or severity of adverse effects can be increased when Erythromycin is combined with Verapamil.]
[N05CD04, estazolam, The metabolism of Estazolam can be decreased when combined with Verapamil.]
[A02BC02, pantoprazole, The metabolism of Pantoprazole can be decreased when combined with Verapamil.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Verapamil.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Verapamil.]
[L01XX11, estramustine, The metabolism of Estramustine can be decreased when combined with Verapamil.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Verapamil.]
[J04AK02, ethambutol, The metabolism of Verapamil can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Verapamil can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Verapamil can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Verapamil.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C01CA15, gepefrine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Gepefrine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Verapamil.]
[V03AF05, amifostine, The risk or severity of adverse effects can be increased when Verapamil is combined with Amifostine.]
[C01BD05, ibutilide, Ibutilide may increase the arrhythmogenic activities of Verapamil.]
[N03AD01, ethosuximide, Ethosuximide may increase the arrhythmogenic activities of Verapamil.]
[M01AC06, meloxicam, The metabolism of Meloxicam can be decreased when combined with Verapamil.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Verapamil.]
[C01CA01, etilefrine, The therapeutic efficacy of Etilefrine can be decreased when used in combination with Verapamil.]
[N01AX07, etomidate, The therapeutic efficacy of Etomidate can be decreased when used in combination with Verapamil.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Verapamil.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Verapamil.]
[C01BA05, ajmaline, Verapamil may increase the arrhythmogenic activities of Ajmaline.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Verapamil.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Verapamil.]
[R06AX12, terfenadine, The metabolism of Verapamil can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Verapamil may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The metabolism of Bupropion can be decreased when combined with Verapamil.]
[N06AB08, fluvoxamine, The metabolism of Verapamil can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, Verapamil may increase the arrhythmogenic activities of Tocainide.]
[C01BC08, encainide, Verapamil may increase the arrhythmogenic activities of Encainide.]
[L02AE02, leuprolide, Leuprolide may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C10AA03, pravastatin, The serum concentration of Pravastatin can be increased when it is combined with Verapamil.]
[M01CB01, gold sodium thiomalate, Verapamil may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[A05AA01, chenodeoxycholic acid, The metabolism of Chenodeoxycholic acid can be decreased when combined with Verapamil.]
[B05AA05, dextran, Verapamil may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A02BA03, famotidine, The metabolism of Verapamil can be decreased when combined with Famotidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Verapamil can be increased when combined with Albendazole.]
[C08CA02, felodipine, Verapamil may increase the arrhythmogenic activities of Felodipine.]
[C08EA01, fendiline, Verapamil may increase the arrhythmogenic activities of Fendiline.]
[N03AX26, fenfluramine, The metabolism of Verapamil can be decreased when combined with Fenfluramine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Verapamil.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Verapamil.]
[R03CC02, albuterol, The therapeutic efficacy of Salbutamol can be decreased when used in combination with Verapamil.]
[L01BB06, clofarabine, The risk or severity of adverse effects can be increased when Clofarabine is combined with Verapamil.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Verapamil.]
[G04BD02, flavoxate, Verapamil may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The risk or severity of adverse effects can be increased when Verapamil is combined with Flecainide.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Verapamil can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Verapamil may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[H02AA02, fludrocortisone, The metabolism of Fludrocortisone can be decreased when combined with Verapamil.]
[V03AB25, flumazenil, Verapamil may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07XB01, flumethasone, The metabolism of Flumethasone can be decreased when combined with Verapamil.]
[N07CA03, flunarizine, Verapamil may increase the arrhythmogenic activities of Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Flunitrazepam can be decreased when combined with Verapamil.]
[D07AC08, fluocinonide, The metabolism of Fluocinonide can be decreased when combined with Verapamil.]
[H02AB03, fluocortolone, The metabolism of Fluocortolone can be decreased when combined with Verapamil.]
[V03AZ01, ethanol, The serum concentration of Ethanol can be increased when it is combined with Verapamil.]
[L01BC09, floxuridine, The metabolism of Verapamil can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Verapamil.]
[N06AB03, fluoxetine, The metabolism of Verapamil can be decreased when combined with Fluoxetine.]
[N05AF01, flupenthixol, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Flupentixol.]
[N05CD01, flurazepam, The metabolism of Flurazepam can be decreased when combined with Verapamil.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N05AG01, fluspirilene, Verapamil may increase the arrhythmogenic activities of Fluspirilene.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Verapamil.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[S02AA17, fosfomycin, Verapamil may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Verapamil.]
[N06BX17, adrafinil, The therapeutic efficacy of Adrafinil can be decreased when used in combination with Verapamil.]
[M03AA01, alcuronium, Verapamil may increase the neuromuscular blocking activities of Alcuronium.]
[G01AX06, furazolidone, Furazolidone may increase the orthostatic hypotensive activities of Verapamil.]
[J05AE10, darunavir, The serum concentration of Verapamil can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Verapamil.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Verapamil.]
[M03AC02, gallamine, Verapamil may increase the neuromuscular blocking activities of Gallamine.]
[C08DA02, gallopamil, Verapamil may increase the arrhythmogenic activities of Gallopamil.]
[S01AD09, ganciclovir, The excretion of Ganciclovir can be decreased when combined with Verapamil.]
[N03AA04, barbexaclone, Barbexaclone may increase the hypotensive activities of Verapamil.]
[C10AB04, gemfibrozil, The metabolism of Verapamil can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Verapamil may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Verapamil.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Verapamil.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Verapamil.]
[A10BJ02, liraglutide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Liraglutide.]
[J05AG04, etravirine, The metabolism of Etravirine can be decreased when combined with Verapamil.]
[A12AA10, calcium gluceptate, The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium glucoheptonate.]
[A12AA30, calcium levulinate, The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium levulinate.]
[N03AD03, methsuximide, Verapamil may increase the arrhythmogenic activities of Methsuximide.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be decreased when combined with Verapamil.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Verapamil.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Verapamil.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Verapamil.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Verapamil.]
[A10BB07, glipizide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Glipizide.]
[N05CM18, dexmedetomidine, The therapeutic efficacy of Dexmedetomidine can be decreased when used in combination with Verapamil.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Verapamil.]
[C05AE01, nitroglycerin, Verapamil may increase the vasodilatory activities of Nitroglycerin.]
[C01BD04, dofetilide, The serum concentration of Dofetilide can be increased when it is combined with Verapamil.]
[C02CA04, doxazosin, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Verapamil.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Esmolol.]
[M01CB04, aurothioglucose, Verapamil may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Verapamil may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Verapamil.]
[C09AA09, fosinopril, The risk or severity of adverse effects can be increased when Fosinopril is combined with Verapamil.]
[S01EX01, guanethidine, Verapamil may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Goserelin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Verapamil.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Verapamil.]
[N01AB01, halothane, The risk or severity of myocardial depression can be increased when Verapamil is combined with Halothane.]
[N05AH04, quetiapine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.]
[N06BX13, idebenone, Verapamil may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[A10AD05, insulin aspart, human, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin aspart.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Verapamil.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C09CA01, losartan, Verapamil may increase the arrhythmogenic activities of Losartan.]
[B05CB03, magnesium citrate, The risk or severity of hypotension can be increased when Magnesium citrate is combined with Verapamil.]
[A12CC03, magnesium gluconate, The risk or severity of hypotension can be increased when Magnesium gluconate is combined with Verapamil.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Verapamil.]
[A07EC02, mesalamine, The risk or severity of bleeding can be increased when Verapamil is combined with Mesalazine.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Verapamil.]
[N05CA16, hexobarbital, Hexobarbital may increase the hypotensive activities of Verapamil.]
[R03CC05, hexoprenaline, The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Verapamil.]
[J05AG01, nevirapine, The metabolism of Verapamil can be increased when combined with Nevirapine.]
[C08CA10, nilvadipine, Verapamil may increase the arrhythmogenic activities of Nilvadipine.]
[M02AA26, nimesulide, Verapamil may increase the arrhythmogenic activities of Nimesulide.]
[C09AA04, perindopril, The risk or severity of adverse effects can be increased when Verapamil is combined with Perindopril.]
[C02DB02, hydralazine, The risk or severity of adverse effects can be increased when Verapamil is combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Verapamil.]
[S02BA01, hydrocortisone, The metabolism of Hydrocortisone can be decreased when combined with Verapamil.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Verapamil may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[G04BD06, propiverine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Verapamil.]
[B05AA07, hetastarch, Verapamil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[G03DA03, 17-alpha-hydroxyprogesterone, The metabolism of Hydroxyprogesterone can be decreased when combined with Verapamil.]
[N05BB01, hydroxyzine, The metabolism of Hydroxyzine can be decreased when combined with Verapamil.]
[J04AB04, rifabutin, The metabolism of Rifabutin can be decreased when combined with Verapamil.]
[C02AC06, rilmenidine, The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Verapamil.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Verapamil.]
[B05XA08, sodium acetate, Verapamil may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Verapamil.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Verapamil.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Verapamil.]
[H01AC02, somatrem, The metabolism of Verapamil can be increased when combined with Somatrem.]
[N01AH03, sufentanil, The metabolism of Sufentanil can be decreased when combined with Verapamil.]
[N06AA02, imipramine, Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Verapamil.]
[R01AD07, tixocortol, Verapamil may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be decreased when used in combination with Verapamil.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Verapamil.]
[C03BA11, indapamide, The metabolism of Indapamide can be decreased when combined with Verapamil.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C02CA02, indoramin, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.]
[A11HA07, inositol, Verapamil may decrease the excretion rate of Inositol which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The metabolism of Verapamil can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Verapamil can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The metabolism of Milnacipran can be decreased when combined with Verapamil.]
[S01XA28, varenicline, Verapamil may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Verapamil.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Verapamil.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Verapamil.]
[A10BH02, vildagliptin, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Vildagliptin.]
[C10AA06, cerivastatin, The metabolism of Cerivastatin can be decreased when combined with Verapamil.]
[L01XX35, anagrelide, The metabolism of Verapamil can be decreased when combined with Anagrelide.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Alprenolol.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB09, interferon alfacon-1, The metabolism of Verapamil can be decreased when combined with Interferon alfacon-1.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Verapamil.]
[N06AF05, iproniazid, Iproniazid may increase the orthostatic hypotensive activities of Verapamil.]
[J05AB13, penciclovir, The metabolism of Verapamil can be decreased when combined with Penciclovir.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the orthostatic hypotensive activities of Verapamil.]
[P01AX06, atovaquone, The metabolism of Atovaquone can be decreased when combined with Verapamil.]
[R03CC06, isoetharine, The therapeutic efficacy of Isoetharine can be decreased when used in combination with Verapamil.]
[C09AA16, imidapril, The risk or severity of adverse effects can be increased when Verapamil is combined with Imidapril.]
[N01AB06, isoflurane, The risk or severity of myocardial depression can be increased when Verapamil is combined with Isoflurane.]
[J04AC01, isoniazid, The metabolism of Verapamil can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Verapamil may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Verapamil.]
[A10BJ01, exenatide, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Exenatide.]
[C01DA14, isosorbide mononitrate, Verapamil may increase the vasodilatory activities of Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, Verapamil may increase the vasodilatory activities of Isosorbide dinitrate.]
[D10BA01, isotretinoin, The metabolism of Isotretinoin can be decreased when combined with Verapamil.]
[C04AA01, isoxsuprine, The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Verapamil.]
[P02CF01, ivermectin, The metabolism of Ivermectin can be decreased when combined with Verapamil.]
[N06AX18, reboxetine, The metabolism of Reboxetine can be decreased when combined with Verapamil.]
[S01AA24, kanamycin, Verapamil may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[H01AC01, somatropin, The metabolism of Verapamil can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Verapamil can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Verapamil.]
[C02KD01, ketanserin, Verapamil may increase the hypotensive activities of Ketanserin.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Verapamil.]
[H02CA04, levoketoconazole, The metabolism of Verapamil can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Verapamil can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[V03AC03, deferasirox, The serum concentration of Verapamil can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Verapamil can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The therapeutic efficacy of Arbutamine can be decreased when used in combination with Verapamil.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Verapamil.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01MB02, nalidixic acid, The metabolism of Verapamil can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Verapamil is combined with Labetalol.]
[N04BB01, amantadine, The risk or severity of adverse effects can be increased when Verapamil is combined with Amantadine.]
[J05AX09, maraviroc, The metabolism of Maraviroc can be decreased when combined with Verapamil.]
[C02AA05, deserpidine, Verapamil may increase the hypotensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Verapamil.]
[A06AX03, lubiprostone, The therapeutic efficacy of Lubiprostone can be decreased when used in combination with Verapamil.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Verapamil.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[R05CB06, ambroxol, The metabolism of Ambroxol can be decreased when combined with Verapamil.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be decreased when combined with Verapamil.]
[N04BA01, levodopa, The risk or severity of hypotension and orthostatic hypotension can be increased when Verapamil is combined with Levodopa.]
[S02DA01, lidocaine, Lidocaine may increase the arrhythmogenic activities of Verapamil.]
[C08EX01, lidoflazine, Verapamil may increase the arrhythmogenic activities of Lidoflazine.]
[S01AA21, amikacin, Verapamil may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Verapamil can be decreased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Verapamil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Verapamil.]
[A07DA03, loperamide, The excretion of Loperamide can be decreased when combined with Verapamil.]
[A12AA11, calcium pangamate, The therapeutic efficacy of Verapamil can be decreased when used in combination with Calcium pangamate.]
[N05BA06, lorazepam, The metabolism of Lorazepam can be decreased when combined with Verapamil.]
[C10AA02, lovastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Verapamil is combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Verapamil.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be increased when it is combined with Verapamil.]
[B05XA11, magnesium chloride, The risk or severity of hypotension can be increased when Magnesium chloride is combined with Verapamil.]
[G04BX01, magnesium hydroxide, The risk or severity of hypotension can be increased when Magnesium hydroxide is combined with Verapamil.]
[A12CC10, magnesium oxide, The risk or severity of hypotension can be increased when Magnesium oxide is combined with Verapamil.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the arrhythmogenic activities of Verapamil.]
[L01BA05, pralatrexate, Verapamil may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Verapamil can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Verapamil.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Verapamil.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Mecamylamine is combined with Verapamil.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Verapamil.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Verapamil.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Verapamil.]
[G03DB03, medrogestone, The metabolism of Medrogestone can be decreased when combined with Verapamil.]
[P01BC02, mefloquine, The metabolism of Mefloquine can be decreased when combined with Verapamil.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CH01, melatonin, The therapeutic efficacy of Verapamil can be decreased when used in combination with Melatonin.]
[N06DX01, memantine, The metabolism of Verapamil can be decreased when combined with Memantine.]
[N02AB02, meperidine, The metabolism of Meperidine can be decreased when combined with Verapamil.]
[C01CA11, mephentermine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Mephentermine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Verapamil.]
[N03AA01, mephobarbital, Methylphenobarbital may increase the hypotensive activities of Verapamil.]
[N01BB03, mepivacaine, Verapamil may decrease the excretion rate of Mepivacaine which could result in a higher serum level.]
[G04BX16, tiopronin, Verapamil may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Verapamil.]
[N05AX13, paliperidone, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.]
[C01CA09, metaraminol, The therapeutic efficacy of Metaraminol can be decreased when used in combination with Verapamil.]
[A10BA02, metformin, The excretion of Metformin can be decreased when combined with Verapamil.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Verapamil.]
[H01CB03, lanreotide, Verapamil may increase the bradycardic activities of Lanreotide.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Verapamil.]
[N06BA03, methamphetamine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Metamfetamine.]
[N05CM01, methaqualone, The metabolism of Methaqualone can be decreased when combined with Verapamil.]
[J05AF05, lamivudine, The risk or severity of adverse effects can be increased when Verapamil is combined with Lamivudine.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Verapamil can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Verapamil may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, Methohexital may increase the hypotensive activities of Verapamil.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N02BG08, ziconotide, Verapamil may increase the arrhythmogenic activities of Ziconotide.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Verapamil.]
[N05AA02, methotrimeprazine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Methotrimeprazine.]
[C01CA10, methoxamine, The therapeutic efficacy of Methoxamine can be decreased when used in combination with Verapamil.]
[D05BA02, methoxsalen, The metabolism of Verapamil can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The risk or severity of myocardial depression can be increased when Verapamil is combined with Methoxyflurane.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Verapamil.]
[C02AB01, methyldopa, The therapeutic efficacy of Methyldopa can be decreased when used in combination with Verapamil.]
[V04CG05, methylene blue, Methylene blue may increase the orthostatic hypotensive activities of Verapamil.]
[G02AB01, methylergonovine, The metabolism of Methylergometrine can be decreased when combined with Verapamil.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Verapamil.]
[H02AB04, methylprednisolone, The metabolism of Methylprednisolone can be decreased when combined with Verapamil.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Verapamil.]
[N02CA04, methysergide, The metabolism of Methysergide can be decreased when combined with Verapamil.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Verapamil.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Metronidazole can be decreased when combined with Verapamil.]
[V04CD01, metyrapone, Verapamil may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, Mexiletine may increase the arrhythmogenic activities of Verapamil.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Verapamil.]
[S02AA13, miconazole, The metabolism of Verapamil can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Verapamil.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Verapamil.]
[C01CA17, midodrine, The therapeutic efficacy of Midodrine can be decreased when used in combination with Verapamil.]
[G03XB01, mifepristone, The serum concentration of Verapamil can be increased when it is combined with Mifepristone.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Verapamil.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C09CA03, valsartan, The metabolism of Verapamil can be decreased when combined with Valsartan.]
[D11AX01, minoxidil, The risk or severity of adverse effects can be increased when Minoxidil is combined with Verapamil.]
[L01XX23, mitotane, The metabolism of Verapamil can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Lisdexamfetamine.]
[L03AC01, aldesleukin, The risk or severity of adverse effects can be increased when Aldesleukin is combined with Verapamil.]
[C01BD01, amiodarone, The risk or severity of adverse effects can be increased when Amiodarone is combined with Verapamil.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Verapamil.]
[N02AA01, morphine, The metabolism of Morphine can be decreased when combined with Verapamil.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Verapamil.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Verapamil can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Verapamil can be decreased when combined with Eltrombopag.]
[G04BA01, ammonium chloride, Verapamil may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Verapamil.]
[L04AA06, mycophenolic acid, Verapamil may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[M03AC03, vecuronium, Verapamil may increase the neuromuscular blocking activities of Vecuronium.]
[N05CA02, amobarbital, Amobarbital may increase the hypotensive activities of Verapamil.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Verapamil.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Verapamil.]
[G03XC01, raloxifene, The metabolism of Verapamil can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[N03AB05, fosphenytoin, The serum concentration of Verapamil can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The metabolism of Verapamil can be decreased when combined with Interferon beta-1b.]
[C07AA12, nadolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Nadolol.]
[J01CA04, amoxicillin, Verapamil may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Ropinirole is combined with Verapamil.]
[J01CF06, nafcillin, The therapeutic efficacy of Verapamil can be decreased when used in combination with Nafcillin.]
[V03AB15, naloxone, The metabolism of Verapamil can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Verapamil can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The therapeutic efficacy of Naphazoline can be decreased when used in combination with Verapamil.]
[N06BA01, amphetamine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Verapamil.]
[A10BG01, troglitazone, The metabolism of Verapamil can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of orthostatic hypotension and syncope can be increased when Verapamil is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Verapamil.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Verapamil.]
[L02BG04, letrozole, The metabolism of Letrozole can be decreased when combined with Verapamil.]
[S03AA01, neomycin, Verapamil may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Verapamil is combined with Remifentanil.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Verapamil.]
[C01CX08, levosimendan, Verapamil may increase the arrhythmogenic activities of Levosimendan.]
[B01AC17, tirofiban, Verapamil may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Verapamil.]
[J02AA01, amphotericin B, Verapamil may decrease the nephrotoxic activities of Amphotericin B.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[L03AX16, plerixafor, Verapamil may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Verapamil may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Desvenlafaxine can be decreased when combined with Verapamil.]
[C09CA07, telmisartan, The metabolism of Verapamil can be decreased when combined with Telmisartan.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[H05BX02, paricalcitol, The metabolism of Paricalcitol can be decreased when combined with Verapamil.]
[C01CE01, inamrinone, Verapamil may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[N06AF02, nialamide, Nialamide may increase the orthostatic hypotensive activities of Verapamil.]
[C08CA04, nicardipine, Nicardipine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[C04AE02, nicergoline, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nicergoline.]
[P02DA01, niclosamide, The metabolism of Verapamil can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The metabolism of Verapamil can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, Verapamil may increase the arrhythmogenic activities of Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[V03AB22, amyl nitrite, Verapamil may increase the vasodilatory activities of Amyl Nitrite.]
[C08CA06, nimodipine, Nimodipine may increase the arrhythmogenic activities of Verapamil.]
[C08CA07, nisoldipine, Nisoldipine may increase the arrhythmogenic activities of Verapamil.]
[N05CD02, nitrazepam, The metabolism of Nitrazepam can be decreased when combined with Verapamil.]
[C08CA08, nitrendipine, Verapamil may increase the arrhythmogenic activities of Nitrendipine.]
[R07AX01, nitric oxide, The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Verapamil.]
[J01XE01, nitrofurantoin, Verapamil may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Zaleplon can be decreased when combined with Verapamil.]
[N04BC05, pramipexole, The risk or severity of adverse effects can be increased when Verapamil is combined with Pramipexole.]
[C02DD01, nitroprusside, Verapamil may increase the hypotensive activities of Nitroprusside.]
[N01AX13, nitrous oxide, The risk or severity of myocardial depression can be increased when Verapamil is combined with Nitrous oxide.]
[C01CA03, norepinephrine, The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Verapamil.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Verapamil.]
[S01AE02, norfloxacin, The metabolism of Verapamil can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Bosentan can be decreased when combined with Verapamil.]
[N06AA10, nortriptyline, Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[R05DA07, noscapine, The metabolism of Verapamil can be decreased when combined with Noscapine.]
[L03AB07, interferon beta-1a, The metabolism of Verapamil can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, Verapamil may increase the arrhythmogenic activities of Nylidrin.]
[H01CB02, octreotide, The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Verapamil.]
[L04AC04, rilonacept, The metabolism of Verapamil can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Omeprazole can be decreased when combined with Verapamil.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Verapamil.]
[R03CB03, metaproterenol, The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Verapamil.]
[G04CA02, tamsulosin, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Tamsulosin.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Verapamil.]
[J01CF04, oxacillin, Verapamil may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[A14AA08, oxandrolone, The metabolism of Verapamil can be decreased when combined with Oxandrolone.]
[N05BA04, oxazepam, Verapamil may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Oxprenolol.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Verapamil.]
[C01DX03, oxyfedrine, The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Verapamil.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Verapamil.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Verapamil.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J04AA01, aminosalicylic acid, The risk or severity of bleeding can be increased when Verapamil is combined with Aminosalicylic acid.]
[N05AH05, asenapine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.]
[M03AC01, pancuronium, Verapamil may increase the neuromuscular blocking activities of Pancuronium.]
[J04AB30, capreomycin, Verapamil may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be decreased when combined with Verapamil.]
[G04BE02, papaverine, The risk or severity of adverse effects can be increased when Verapamil is combined with Papaverine.]
[H02AB05, paramethasone, The metabolism of Paramethasone can be decreased when combined with Verapamil.]
[C02KC01, pargyline, Pargyline may increase the orthostatic hypotensive activities of Verapamil.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01MA03, pefloxacin, The metabolism of Verapamil can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Verapamil.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Penbutolol.]
[N05AG03, penfluridol, Verapamil may increase the arrhythmogenic activities of Penfluridol.]
[M01CC01, penicillamine, The excretion of Penicillamine can be decreased when combined with Verapamil.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Verapamil.]
[J01CE09, penicillin G procaine, Verapamil may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Verapamil can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Verapamil may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, The metabolism of Pentoxifylline can be decreased when combined with Verapamil.]
[N04BC02, pergolide, The therapeutic efficacy of Pergolide can be decreased when used in combination with Verapamil.]
[C08EX02, perhexiline, Verapamil may increase the arrhythmogenic activities of Perhexiline.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Verapamil.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Verapamil.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may increase the orthostatic hypotensive activities of Verapamil.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Verapamil.]
[N03AA02, phenobarbital, The metabolism of Phenobarbital can be decreased when combined with Verapamil.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Verapamil.]
[C04AX02, phenoxybenzamine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Verapamil.]
[A08AA01, phentermine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Phentermine.]
[V03AB36, phentolamine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phentolamine.]
[M02AA01, phenylbutazone, The metabolism of Verapamil can be decreased when combined with Phenylbutazone.]
[S01GA05, phenylephrine, The risk or severity of hypertension can be decreased when Verapamil is combined with Phenylephrine.]
[A02BC06, dexlansoprazole, The metabolism of Dexlansoprazole can be decreased when combined with Verapamil.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Verapamil.]
[N03AB02, phenytoin, The serum concentration of Verapamil can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Verapamil can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Verapamil may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Verapamil.]
[B02BA01, vitamin K1, Verapamil may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[C08CX01, mibefradil, Verapamil may increase the arrhythmogenic activities of Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Verapamil.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Pindolol.]
[C10AA05, atorvastatin, The serum concentration of Verapamil can be increased when it is combined with Atorvastatin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Verapamil can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Verapamil.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Verapamil.]
[N06BX03, piracetam, Verapamil may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of adverse effects can be increased when Verapamil is combined with Eprosartan.]
[S01BC06, piroxicam, The metabolism of Piroxicam can be decreased when combined with Verapamil.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be decreased when combined with Verapamil.]
[N02CX01, pizotyline, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Verapamil can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Verapamil can be decreased when combined with Irbesartan.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Verapamil.]
[A10BG02, rosiglitazone, The metabolism of Rosiglitazone can be decreased when combined with Verapamil.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Verapamil.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Verapamil.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Verapamil.]
[L04AC08, canakinumab, The metabolism of Verapamil can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Verapamil can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The metabolism of Saxagliptin can be decreased when combined with Verapamil.]
[B05XA01, potassium chloride, Verapamil may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[A10AD04, insulin lispro, The risk or severity of hypoglycemia can be increased when Verapamil is combined with Insulin lispro.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Verapamil.]
[C07AB01, practolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Practolol.]
[C01BA08, prajmaline, Verapamil may increase the arrhythmogenic activities of Prajmaline.]
[N05BA11, prazepam, The metabolism of Prazepam can be decreased when combined with Verapamil.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Verapamil.]
[C02CA01, prazosin, Prazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[S03BA02, prednisolone, The metabolism of Prednisolone can be decreased when combined with Verapamil.]
[H02AB07, prednisone, The metabolism of Prednisone can be decreased when combined with Verapamil.]
[C01DX02, prenylamine, Verapamil may increase the arrhythmogenic activities of Prenylamine.]
[P01BA03, primaquine, The metabolism of Primaquine can be decreased when combined with Verapamil.]
[N03AA03, primidone, The metabolism of Verapamil can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Verapamil can be increased when combined with Probenecid.]
[C01BA02, procainamide, Verapamil may increase the arrhythmogenic activities of Procainamide.]
[S01HA05, procaine, Procaine may increase the orthostatic hypotensive activities of Verapamil.]
[L01XB01, procarbazine, Procarbazine may increase the orthostatic hypotensive activities of Verapamil.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Verapamil.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Verapamil.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Verapamil.]
[N05AA03, promazine, Promazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Verapamil.]
[G03DB07, promegestone, The metabolism of Promegestone can be decreased when combined with Verapamil.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Verapamil.]
[C01BC03, propafenone, The risk or severity of adverse effects can be increased when Verapamil is combined with Propafenone.]
[A03AB05, propantheline, Verapamil may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Verapamil.]
[N05AC01, periciazine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Periciazine.]
[N05CM06, propiomazine, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiomazine.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Verapamil.]
[N01AX10, propofol, The metabolism of Propofol can be decreased when combined with Verapamil.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be decreased when combined with Verapamil.]
[C07AA05, propranolol, The risk or severity of adverse effects can be increased when Verapamil is combined with Propranolol.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Verapamil.]
[N02CC04, rizatriptan, Verapamil may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, The risk or severity of adverse effects can be increased when Verapamil is combined with Epoprostenol.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Verapamil.]
[R01BA02, pseudoephedrine, The therapeutic efficacy of Verapamil can be decreased when used in combination with Pseudoephedrine.]
[N05AX12, aripiprazole, Verapamil may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.]
[N07XX07, dalfampridine, Verapamil may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Verapamil may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[P01BD01, pyrimethamine, The metabolism of Verapamil can be decreased when combined with Pyrimethamine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Verapamil.]
[C01BA01, quinidine, Verapamil may increase the hypotensive activities of Quinidine.]
[P01BC01, quinine, Verapamil may increase the hypotensive activities of Quinine.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Verapamil.]
[C02AA01, rescinnamine, Verapamil may increase the hypotensive activities of Rescinnamine.]
[C02AA02, reserpine, The metabolism of Verapamil can be increased when combined with Reserpine.]
[J05AP01, ribavirin, Verapamil may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Verapamil can be increased when combined with Rifampicin.]
[R03AC05, rimiterol, The therapeutic efficacy of Rimiterol can be decreased when used in combination with Verapamil.]
[G02CA01, ritodrine, The therapeutic efficacy of Ritodrine can be decreased when used in combination with Verapamil.]
[J01FA06, roxithromycin, The risk or severity of adverse effects can be increased when Roxithromycin is combined with Verapamil.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Verapamil which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of bleeding can be increased when Verapamil is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The risk or severity of bleeding can be increased when Verapamil is combined with Salicylic acid.]
[S01FA02, scopolamine, The metabolism of Scopolamine can be decreased when combined with Verapamil.]
[N05CA06, secobarbital, The metabolism of Verapamil can be increased when combined with Secobarbital.]
[N04BD01, selegiline, Selegiline may increase the orthostatic hypotensive activities of Verapamil.]
[L01FA03, obinutuzumab, The risk or severity of adverse effects can be increased when Verapamil is combined with Obinutuzumab.]
[J01GB08, sisomicin, Verapamil may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Verapamil may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, The therapeutic efficacy of Sorbitol can be decreased when used in combination with Verapamil.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Verapamil is combined with Sotalol.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Verapamil.]
[C03DA01, spironolactone, The metabolism of Verapamil can be decreased when combined with Spironolactone.]
[N03AG01, valproic acid, The metabolism of Verapamil can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Verapamil.]
[C10AA01, simvastatin, HMG Co-A reductase inhibitors - CYP3A4 inhibitors]
[L01CE02, irinotecan, Irinotecan - CYP3A4 inhibitors]
[C10AA02, lovastatin, HMG Co-A reductase inhibitors - CYP3A4 inhibitors]
